INSM - Insmed Incorporated

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development122,72174,27756,292
Selling General and Administrative50,67943,21631,073
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-173,400-117,493-87,365
Income from Continuing Operations
Total Other Income/Expenses Net723228199
Earnings Before Interest and Taxes-172,677-117,265-87,166
Interest Expense3,4982,8892,415
Income Before Tax-176,175-120,154-89,581
Income Tax Expense98-1,971-10,422
Minority Interest---
Net Income From Continuing Ops-176,273-118,183-79,159
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-176,273-118,183-79,159
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-176,273-118,183-79,159